Evidence map›Paper›PMID 33510950›Full record

ArticleTranslational vision science & technology2021

Optical Coherence Tomography Artifacts Are Associated With Adaptive Optics Scanning Light Ophthalmoscopy Success in Achromatopsia.

Katie M Litts, Erica N Woertz, Michalis Georgiou, Emily J Patterson, Byron L Lam, Gerald A Fishman, Mark E Pennesi, Christine N Kay, William W Hauswirth, Michel Michaelides and 1 more

Abstract read
In one paragraph

Article in Translational vision science & technology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Next-Generation Sequencing Applications for Inherited Retinal Diseases.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Katie M LittsDepartment of Ophthalmology & Visual Sciences, Medical College of Wisconsin, Milwaukee, WI, USA.
Erica N WoertzDepartment of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.
Michalis GeorgiouUCL Institute of Ophthalmology, University College London, London, UK.
Emily J PattersonDepartment of Ophthalmology & Visual Sciences, Medical College of Wisconsin, Milwaukee, WI, USA.
Byron L LamBascom Palmer Eye Institute, University of Miami, Miami, FL, USA.
Gerald A FishmanPangere Center for Inherited Retinal Diseases, The Chicago Lighthouse, Chicago, IL, USA.
Mark E PennesiCasey Eye Institute, Oregon Health & Science University, Portland, OR, USA.
Christine N KayVitreoretinal Associates, Gainesville, FL, USA.
William W HauswirthDepartment of Ophthalmology, University of Florida, Gainesville, FL, USA.
Michel MichaelidesUCL Institute of Ophthalmology, University College London, London, UK.
Joseph CarrollDepartment of Ophthalmology & Visual Sciences, Medical College of Wisconsin, Milwaukee, WI, USA.

Funding

Clinical and Translational Science AwardUL1TR001436 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI FREED, JULIE K · 2015 to 2025
$47.5M
Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI John Peter Campbell · 1995 to 2026
$19.4M
Assessing Photoreceptor Structure and Function in Normal and Diseased RetinaeR01EY017607 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI Joseph Carroll · 2008 to 2026
$8.3M
rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research StudiesR24EY022023 · NEI · UNIVERSITY OF FLORIDA · PI HAUSWIRTH, WILLIAM W · 2013 to 2017
$7.9M
Medical Scientist Training ProgramT32GM080202 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI BARBIERI, JOSEPH T, SALZMAN, NITA H · 2010 to 2024
$5.7M
Rresearch Training Program in Vision ScienceT32EY014537 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI Elena V Semina · 2002 to 2026
$4.2M
VISION RES LAB: HERPETIC KERATIC, CORE PIGMENT GENES, RETINITIS PIGMENTOSAC06RR016511 · NCRR · MEDICAL COLLEGE OF WISCONSIN · PI DUNN, MICHAEL J · 2002 to 2002
$1.4M
Multimodal Imaging of Photoreceptor Structure in AchromatopsiaF32EY029148 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI LITTS, KATIE M · 2018 to 2020
$148k
NCATS NIH HHS UL1 TR001436NCRR NIH HHS C06 RR016511NEI NIH HHS F32 EY029148NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY017607NEI NIH HHS R24 EY022023NEI NIH HHS T32 EY014537NIGMS NIH HHS T32 GM080202Wellcome Trust
6 · The paper itself

Abstract

Purpose: To determine whether artifacts in optical coherence tomography (OCT) images are associated with the success or failure of adaptive optics scanning light ophthalmoscopy (AOSLO) imaging in subjects with achromatopsia (ACHM). Methods: Previously acquired OCT and non-confocal, split-detector AOSLO images from one eye of 66 subjects with genetically confirmed achromatopsia (15 Results: There was excellent agreement between the two observers for assessing OCT artifact severity category (weighted kappa = 0.88). Overall, AOSLO success was 47%. For subjects with OCT artifact severity category 1, AOSLO success was 65%; for category 2, 47%; for category 3, 11%; and for category 4, 0%. There was a significant association between OCT artifact severity category and AOSLO success ( Conclusions: Artifacts in OCT volumes are associated with AOSLO success in ACHM. Subjects with less severe OCT artifacts are more likely to be good candidates for AOSLO imaging, whereas AOSLO was successful in only 7% of subjects with category 3 or 4 OCT artifacts. These results may be useful in guiding patient selection for AOSLO imaging. Translational Relevance: Using OCT to prescreen patients could be a valuable tool for clinical trials that utilize AOSLO to reduce costs and decrease patient testing burden.

Indexed as

ArtifactsColor Vision DefectsHumansOphthalmoscopyTomography, Optical CoherenceVisual Acuityachromatopsiaadaptive opticsinherited retinal diseaseoptical coherence tomography

Identifiers

PMID33510950
PMCPMC7804582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.